The chemo cost for lymphoma isn't one number — it depends on how many cycles you need, the drug class in your regimen, and where treatment is given. This guide breaks down each factor honestly, and how CION gives you a written estimate up front.
If you've just been diagnosed, one of the first practical questions is what treatment will cost. The honest answer is that lymphoma chemotherapy cost is not a fixed figure — it's built up from several parts, and those parts differ from person to person. The same disease name can lead to very different bills depending on the subtype, the stage, and the exact regimen your specialist chooses.
Three things move the cost more than anything else: the number of cycles your plan needs, the drug class in your regimen (standard chemotherapy alone versus chemotherapy plus a monoclonal antibody), and whether treatment runs as a day-care infusion or an inpatient stay. Everything else — supportive medicines, blood tests, scans — sits around these.
This page explains each cost driver in plain language so you can ask the right questions and plan ahead. For the full picture across all treatment types, see our lymphoma treatment cost in Hyderabad page, and for how care is delivered, our Lymphoma Treatment in Hyderabad page. You can also explore the full Lymphoma hub.
For many B-cell lymphomas, guidelines from NCCN and ESMO recommend adding an anti-CD20 monoclonal antibody to chemotherapy when the tumour cells carry the CD20 marker — a decision that improves outcomes but is also the single biggest driver of chemo cost, because these biologic drugs are far more expensive than standard chemotherapy agents. That is exactly why two people with "lymphoma" can face very different bills. (Source: NCCN and ESMO clinical practice guidelines for lymphoma.)
Each cycle's cost is the sum of these components. Understanding them helps you read an estimate and know which questions to ask before you start.
| Cost factor | Why it matters | Impact on cost |
|---|---|---|
| Number of cycles | Set by subtype & stage; most plans run several cycles, 2–3 weeks apart | Multiplies the per-cycle cost across the course |
| Drug class | Standard chemotherapy vs chemotherapy plus an anti-CD20 monoclonal antibody or targeted agent | Largest single variable — antibodies cost far more |
| Treatment setting | Day-care infusion vs inpatient admission | Day-care avoids room/stay charges |
| Supportive care | Anti-nausea medicines, growth-factor injections, blood-count support | Adds a smaller, recurring amount per cycle |
| Diagnostics & monitoring | PET-CT, blood tests and reviews during treatment | Usually costed separately from the chemo itself |
This is a general guide to cost structure, not a price list. Actual figures depend on your regimen, dosing and setting — CION provides a written, itemised estimate for your specific plan.
These are the levers that decide whether the cost of your lymphoma chemo course sits at the lower or higher end.
Your subtype and stage decide how many cycles you need. Because a single per-cycle figure repeats across the whole course, the cycle count is one of the biggest determinants of the total. A written estimate should always show the full planned course, not just cycle one.
This moves the cost the most. Standard chemotherapy agents are relatively economical; adding an anti-CD20 monoclonal antibody for suitable B-cell lymphomas — a biologic drug — is the single most expensive line item. We describe regimens by drug class here; specific regimen names are covered on the treatment page.
Most lymphoma chemotherapy is given as a day-care infusion — you come in, receive treatment, and go home the same day. This avoids the room and stay charges of an inpatient admission, which are reserved for cycles or situations that genuinely need closer monitoring.
Around each cycle you'll need anti-nausea medicines, sometimes growth-factor injections to protect blood counts, and regular blood tests. Individually modest, these recur every cycle. Scans such as PET-CT are costed separately. CION delivers this supportive care in-house.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Meet CION's lymphoma specialists at a NABH-accredited hospital, get a clear written estimate, and understand exactly what your chemo plan will cost.
The bill you see is rarely the amount you pay out of pocket. For most families, the largest share of lymphoma chemotherapy cost can be met through insurance or a government scheme — and getting this in place before you start is one of the most effective ways to keep costs manageable.
Most policies cover hospitalisation-based chemotherapy, and many now include day-care chemo even without an overnight stay. What matters is your sum insured, any room-rent cap, and which specific drugs are approved. CION's cashless desk reviews your policy and handles pre-authorisation so billing runs smoothly. Our insurance & cashless guide walks through what to confirm first.
For eligible families, state schemes can cover a large part of treatment. In Telangana, see whether Aarogyasri covers lymphoma treatment; in Andhra Pradesh, see NTR Vaidya Seva cover. Approved packages, drug lists and limits differ by scheme, so it's worth checking eligibility early rather than after the first cycle.
For most people starting out, first-line chemotherapy in day-care is the main and most manageable cost. It's worth knowing how the bigger-ticket treatments compare, because they apply only in specific situations — usually relapsed or high-risk disease decided at a tumour board, not routine first treatment.
The vast majority of patients never need a transplant or cell therapy — these are reserved for specific clinical situations, not everyday first-line care.
A higher price tag does not mean a better result. Guideline-based care from NCCN and ESMO matches the regimen to the lymphoma subtype — and published series report survival in the region of ~80–90% for Hodgkin lymphoma and ~60–70% for diffuse large B-cell lymphoma, though figures vary by individual, stage and subtype. Spending on treatment your subtype does not need adds cost without benefit, which is why CION reviews every case at a tumour board before quoting a plan. (Source: NCCN and ESMO lymphoma guidelines; published outcome series.)
A little planning goes a long way. These practical steps help you avoid surprises and make sure you're paying for the right care:
CION explains every line item before treatment begins — you deserve a plan built around healing, not billing. Request your cost estimation or call 18002028726.
Get a free written second opinion and an itemised estimate from CION's haematology-oncology team — with insurance and scheme cover checked, so you can plan with confidence.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.The chemo cost for lymphoma is driven mainly by a few things: the number of cycles your plan needs, the drug class used (standard chemotherapy is far less costly than an added anti-CD20 monoclonal antibody), whether treatment is given as a day-care infusion or an inpatient stay, and the supportive care around each cycle — anti-nausea medicines, growth-factor injections and blood tests. The lymphoma subtype and stage set how many cycles are needed. Diagnostic scans such as a PET-CT are usually costed separately. For a written, itemised estimate for your specific plan, request a cost estimation or see our lymphoma treatment cost in Hyderabad page.
The cost of a lymphoma chemo cycle varies widely because it depends on which drugs are in the regimen, your body-surface-area-based dosing, the day-care versus inpatient setting, and the supportive medicines given with it. A cycle using standard chemotherapy drugs alone sits at the lower end; a cycle that adds an anti-CD20 monoclonal antibody or other targeted agent costs substantially more, as these biologic drugs are the largest single line item. Most lymphoma plans run several cycles spaced two to three weeks apart, so the per-cycle figure multiplies across the course. Because pricing is so plan-specific, CION gives a written per-cycle and full-course estimate up front rather than a single headline number. Get a cost estimation for your regimen.
Many B-cell lymphomas carry the CD20 marker on their surface, and adding an anti-CD20 monoclonal antibody to chemotherapy improves outcomes in these cases — which is why guidelines from NCCN and ESMO include it for suitable patients. These antibodies are biologic drugs, manufactured very differently from ordinary chemotherapy tablets or injections, and are the single most expensive component of a modern lymphoma regimen. The antibody is usually given with each chemo cycle, so its cost recurs across the course. Whether it belongs in your plan depends on your subtype and CD20 status, decided at the tumour board. We explain regimen specifics on the Lymphoma Treatment in Hyderabad page.
Yes, most cases can be part-funded. Private health insurance commonly covers hospitalisation-based chemotherapy, and many policies now include day-care chemo — CION has a cashless desk that checks your policy and handles pre-authorisation. For eligible families, state schemes can cover a large share of treatment: see Aarogyasri cover in Telangana and NTR Vaidya Seva in Andhra Pradesh. Coverage limits, room-rent caps and the specific drugs approved vary by policy and scheme, so the actual out-of-pocket amount differs from person to person. Our insurance & cashless guide walks through what to check before you start.
For most people starting treatment, first-line chemotherapy given in day-care is the main and most manageable cost. A stem cell transplant — considered mainly for relapsed or high-risk lymphoma — is a much larger, one-time cost because it involves an extended hospital stay, high-dose conditioning and intensive monitoring; at CION this is coordinated through accredited partner facilities rather than delivered in-house. Newer cell therapy is costlier still; see stem cell transplant cost and CAR T-cell therapy cost in India. Most patients never need these — they are reserved for specific situations decided by the tumour board.
A few practical steps help. Ask for a written, itemised estimate covering the full planned course, not just the first cycle, so there are no surprises. Confirm whether your regimen includes a monoclonal antibody, as that changes the total the most. Use day-care infusions where clinically appropriate, which avoids inpatient room costs. Complete your insurance pre-authorisation before starting so cashless billing runs smoothly, and check scheme eligibility early. Finally, get a second opinion to confirm the plan is right-sized — neither under- nor over-treating. CION explains every line item before treatment begins; request your cost estimation.
No. The right regimen for your lymphoma subtype and stage is what drives outcomes — not the price tag. Guideline-based care from NCCN and ESMO matches the drugs to the disease: some lymphomas do best with standard chemotherapy alone, while others benefit from adding a monoclonal antibody, and each choice has a different cost. Published series report survival in the region of ~80–90% for Hodgkin lymphoma and ~60–70% for diffuse large B-cell lymphoma, though figures vary by individual, stage and subtype. Spending more on treatment your subtype does not need adds cost without benefit. This is exactly why CION reviews every case at a tumour board and gives an honest, plan-matched estimate.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.